These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2797925)

  • 21. Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours.
    Maesen FP; Smeets JJ; Gubbelmans HL; Zweers PG
    Chest; 1990 Mar; 97(3):590-4. PubMed ID: 1968371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics.
    Rosenborg J; Bengtsson T; Larsson P; Blomgren A; Persson G; Lötvall J
    Eur J Clin Pharmacol; 2000 Aug; 56(5):363-70. PubMed ID: 11009043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma.
    Kozlik-Feldmann R; von Berg A; Berdel D; Reinhardt D
    Eur J Med Res; 1996 Jul; 1(10):465-70. PubMed ID: 9438143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma.
    Bartow RA; Brogden RN
    Drugs; 1998 Feb; 55(2):303-22. PubMed ID: 9506248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formoterol vs. albuterol administered via Turbuhaler system in the emergency treatment of acute asthma in children.
    Avila-Castañón L; Casas-Becerra B; Del Río-Navarro BE; Velázquez-Armenta Y; Sienra-Monge JJ
    Allergol Immunopathol (Madr); 2004; 32(1):18-20. PubMed ID: 14980191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Speeds of action of single doses of formoterol and salbutamol compared with placebo in reversing methacholine-induced bronchoconstriction.
    Beach JR; Bromly CL; Avery AJ; Reid RW; Walters EH; Hendrick DJ
    Pulm Pharmacol; 1996 Aug; 9(4):245-9. PubMed ID: 9160413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
    Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formoterol in the treatment of nocturnal asthma.
    Maesen FP; Smeets JJ; Gubbelmans HL; Zweers PG
    Chest; 1990 Oct; 98(4):866-70. PubMed ID: 1976487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formoterol, a new long-acting beta 2 agonist, inhaled twice daily, in stable asthmatic subjects.
    Midgren B; Melander B; Persson G
    Chest; 1992 Apr; 101(4):1019-22. PubMed ID: 1348219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, followed by a 12-month trial with formoterol.
    Steffensen I; Faurschou P; Riska H; Rostrup J; Wegener T
    Allergy; 1995 Aug; 50(8):657-63. PubMed ID: 7503401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formoterol, a new long-acting selective beta 2-agonist, decreases airway responsiveness in children with asthma.
    Becker AB; Simons FE
    Lung; 1990; 168 Suppl():99-102. PubMed ID: 1974689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma.
    Boonsawat W; Charoenratanakul S; Pothirat C; Sawanyawisuth K; Seearamroongruang T; Bengtsson T; Brander R; Selroos O
    Respir Med; 2003 Sep; 97(9):1067-74. PubMed ID: 14509562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients.
    Grembiale RD; Pelaia G; Naty S; Vatrella A; Tranfa CM; Marsico SA
    Pulm Pharmacol Ther; 2002; 15(5):463-6. PubMed ID: 12406669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duration of action of formoterol and salbutamol dry-powder inhalation in prevention of exercise-induced asthma in children.
    Daugbjerg P; Nielsen KG; Skov M; Bisgaard H
    Acta Paediatr; 1996 Jun; 85(6):684-7. PubMed ID: 8816204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term efficacy of formoterol compared to salbutamol.
    Hekking PR; Maesen F; Greefhorst A; Prins J; Tan Y; Zweers P
    Lung; 1990; 168 Suppl():76-82. PubMed ID: 1974686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect and duration of action of inhaled formoterol and salbutamol on exercise-induced asthma in children.
    Henriksen JM; Agertoft L; Pedersen S
    J Allergy Clin Immunol; 1992 Jun; 89(6):1176-82. PubMed ID: 1351489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol.
    Bateman ED; Fairall L; Lombardi DM; English R
    Respir Res; 2006 Jan; 7(1):13. PubMed ID: 16433920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by a pMDI.
    Seberová E; Andersson A
    Respir Med; 2000 Jun; 94(6):607-11. PubMed ID: 10921767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of formoterol metered aerosol in children.
    von Berg A; Berdel D
    Lung; 1990; 168 Suppl():90-8. PubMed ID: 1974688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.